Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris

ClinicalTrials.gov ID: NCT03271021

Public ClinicalTrials.gov record NCT03271021. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 1:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 for 12 Weeks in the Treatment of Moderate-to-Severe Acne Vulgaris (Study FX2017-22)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 for 12 Weeks in the Treatment of Moderate-to-Severe Acne Vulgaris (Study FX2017-22)

Study identification

NCT ID
NCT03271021
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Vyne Therapeutics Inc.
Industry
Enrollment
1,488 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
9 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 17, 2017 (Actual)
Primary completion
Sep 4, 2018 (Actual)
Completion
Sep 4, 2018 (Actual)
Last update posted
Jan 18, 2022

2017 – 2018

United States locations

U.S. sites
98
U.S. states
28
U.S. cities
86
Facility City State ZIP Site status
Foamix Investigational Site #376 Phoenix Arizona 85023 —
Foamix Investigational Site #395 Tucson Arizona 85712 —
Foamix Investigational Site #315 Bryant Arkansas 72022 —
Foamix Investigational Site #340 Fort Smith Arkansas 72916 —
Foamix Investigational SIte #377 Little Rock Arkansas 72212 —
Foamix Investigational Site #366 Encino California 91436 —
Foamix Investigational Site #403 Los Angeles California 90036 —
Foamix Investigational Site #303 Murrieta California 92562 —
Foamix Investigational Site #369 Northridge California 91324 —
Foamix Investigational Site #387 Palm Springs California 92262 —
Foamix Investigational Site #393 Pasadena California 91105 —
Foamix Investigational Site #380 Poway California 92064 —
Foamix Investigational Site # 328 Sacramento California 95819 —
Foamix Investigational Site #313 San Diego California 92123 —
Foamix Investigational Site #336 San Luis Obispo California 93405 —
Foamix Investigational Site #309 Santa Ana California 92705 —
Foamix Investigational Site #325 Santa Monica California 90403 —
Foamix Investigational Site #375 Temecula California 92592 —
Foamix Investigational Site #381 Aventura Florida 33180 —
Foamix Investigational SIte #371 Boca Raton Florida 33431 —
Foamix Investigational Site #311 Boca Raton Florida 33486 —
Foamix Investigational Site #398 Brandon Florida 33511 —
Foamix Investigational Site #329 Clearwater Florida 33756 —
Foamix Investigational Site #378 Davie Florida 33328 —
Foamix Investigational Site #396 DeLand Florida 32720 —
Foamix Investigational Site #392 Doral Florida 33126 —
Foamix Investigational Site #318 Fort Myers Florida 33912 —
Foamix Investigational Site #401 Hialeah Florida 33015 —
Foamix Investigational Site #400 Hialeah Florida 33016 —
Foamix Investigational Site #383 Lake Worth Florida 33467 —
Foamix Investigational Site #397 Miami Florida 33126 —
Foamix Investigational Site #370 Miami Florida 33155 —
Foamix Investigational Site #346 Miami Lakes Florida 33016 —
Foamix Investigational Site #347 Miami Lakes Florida 33104 —
Foamix Investigational Site #306 North Miami Beach Florida 33162 —
Foamix Investigational Site #312 Ormond Beach Florida 32174 —
Foamix Investigational Site #362 South Miami Florida 33143 —
Foamix Investigational SIte #382 Tamarac Florida 33321 —
Foamix Investigational Site #399 Tampa Florida 33609 —
Foamix Investigational Site #385 Tampa Florida 33624 —
Foamix Investigational Site #394 Tampa Florida 33634 —
Foamix Investigational Site #360 West Palm Beach Florida 33406 —
Foamix Investigational Site #368 Columbus Georgia 31904 —
Foamix Investigational Site #336 Sandy Springs Georgia 30328 —
Foamix Investigational Site #384 Nampa Idaho 83651 —
Foamix Investigational Site #345 Skokie Illinois 60077 —
Foamix Investigational Site #390 West Dundee Illinois 60118 —
Foamix Investigational Site #365 Indianapolis Indiana 46256 —
Foamix Investigational Site #316 New Albany Indiana 47150 —
Foamix Investigational Site #361 Plainfield Indiana 46168 —
Foamix Investigational Site #331 South Bend Indiana 46617 —
Foamix Investigational Site #320 Louisville Kentucky 40217 —
Foamix Investigational SIte #367 Louisville Kentucky 40241 —
Foamix Investigational Site #317 New Orleans Louisiana 70115 —
Foamix Investigational SIte #373 New Orleans Louisiana 70124 —
Foamix Investigational Site #388 Glenn Dale Maryland 20769 —
Foamix Investigational Site #304 Beverly Massachusetts 01915 —
Foamix Investigational Site #314 Brighton Massachusetts 02135 —
Foamix Investigational Site #334 Watertown Massachusetts 02472 —
Foamix Investigational Site #322 Saint Joseph Missouri 64506 —
Foamix Investigational Site #372 St Louis Missouri 63141 —
Foamix Investigational Site #391 Lincoln Nebraska 68502 —
Foamix Investigational Site # 327 Omaha Nebraska 68144 —
Foamix Investigational Site #332 Las Vegas Nevada 89728 —
Foamix Investigational Site #344 Portsmouth New Hampshire 03801 —
Foamix Investigational Site #356 Berlin New Jersey 08009 —
Foamix Investigational Site #337 Verona New Jersey 07044 —
Foamix Investigational Site #321 Charlotte New York 28277 —
Foamix Investigational Site #355 New York New York 10016 —
Foamix Investigational Site #363 New York New York 10155 —
Foamix Investigational Site #307 Stony Brook New York 11790 —
Foamix Investigational Site #350 Charlotte North Carolina 28277 —
Foamix Investigational Site #348 Winston-Salem North Carolina 27104 —
Foamix Investigational Site #364 Fargo North Dakota 58103 —
Foamix Investigational Site #310 Bexley Ohio 43209 —
Foamix Investigational Site #386 Cincinnati Ohio 45212 —
Foamix Investigational Site #353 Cleveland Ohio 44122 —
Foamix Investigational Site #330 Dublin Ohio 43016 —
Foamix Investigational Site #302 Norman Oklahoma 73071 —
Foamix Investigational Site #335 Exton Pennsylvania 19341 —
Foamix Investigational Site #349 Hershey Pennsylvania 17033 —
Foamix Investigational Site #323 Jenkintown Pennsylvania 19046 —
Foamix Investigational Site #319 Charleston South Carolina 29407 —
Foamix Investigational Site #305 Mt. Pleasant South Carolina 29464 —
Foamix Investigational Site #308 Knoxville Tennessee 37922 —
Foamix Research Site # 301 Arlington Texas 76011 —
Foamix Investigational Site #374 Arlington Texas 76014 —
Foamix Investigational SIte #341 Austin Texas 78704 —
Foamix Investigational Site #351 Austin Texas 78705 —
Foamix Investigational Site #402 Bryan Texas 77802 —
Foamix Investigational Site #358 Dallas Texas 75231 —
Foamix Investigational Site #333 Houston Texas 77004 —
Foamix Investigational Site #352 Houston Texas 77056 —
Foamix Investigational Site # 324 Pflugerville Texas 78660 —
Foamix Investigational SIte #379 Lynchburg Virginia 24501 —
Foamix Investigational Site #343 Norfolk Virginia 235070 —
Foamix Investigational Site #389 Seattle Washington 98168 —
Foamix Investigational Site #359 Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03271021, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 18, 2022 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03271021 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →